Voglibose bioequivalence [Bioanalytics]

posted by pharmwhiz  – 2009-12-10 05:40 (6040 d 02:55 ago) – Posting: # 4451
Views: 5,989

(edited on 2009-12-10 10:11)

Dear Manojkarwa:
I too faced the same question and found clarity in the following paper.
let me know if useful

CLINICAL THERAPEUTICS®/VOL. 19, NO. 4, 1997
Comparison of the Effects of Acarbose and Voglibose in Healthy Subjects
Shigeru Kageyama, MD Noboru Nakamichi, MD, Hisayuki Sekino, MD, and Shigeyuki Nakano, MD

Contact me if you need full length paper

Chandramouli R


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
Edit: I removed your e-mail from the post and activated the e-mail-link in your profile. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
140 visitors (0 registered, 140 guests [including 19 identified bots]).
Forum time: 09:35 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5